These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6842678)

  • 1. Role of antibodies and host cells in plaque enhancement of Murray Valley encephalitis virus.
    Kliks SC; Halstead SB
    J Virol; 1983 May; 46(2):394-404. PubMed ID: 6842678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murray Valley encephalitis in Australia, 1974: antibody response in cases and community.
    Doherty RL; Carley JG; Filippich C; White J; Gust ID
    Aust N Z J Med; 1976 Oct; 6(5):446-53. PubMed ID: 1071876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunisation with gamma globulin to murray valley encephalitis virus and with an inactivated Japanese encephalitis virus vaccine as prophylaxis against australian encephalitis: evaluation in a mouse model.
    Broom AK; Wallace MJ; Mackenzie JS; Smith DW; Hall RA
    J Med Virol; 2000 Jun; 61(2):259-65. PubMed ID: 10797383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.
    Halstead SB; O'Rourke EJ
    J Exp Med; 1977 Jul; 146(1):201-17. PubMed ID: 406347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated infection of macrophages and macrophage-like cell lines with 17D-yellow fever virus.
    Schlesinger JJ; Brandriss MW
    J Med Virol; 1981; 8(2):103-17. PubMed ID: 7299376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An explanation for enhanced virus plaque formation in chick embryo cells.
    Kliks SC; Halstead SB
    Nature; 1980 Jun; 285(5765):504-5. PubMed ID: 7402295
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancing antibodies, macrophages and virulence in mouse cytomegalovirus infection.
    Inada T; Chong KT; Mims CA
    J Gen Virol; 1985 Apr; 66 ( Pt 4)():871-8. PubMed ID: 2984321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murray Valley encephalitis virus infection in mosquitoes and domestic fowls in Queensland, 1974.
    Doherty RL; Carley JG; Kay BH; Filippich C; Marks EN
    Aust J Exp Biol Med Sci; 1976 Jun; 54(3):237-43. PubMed ID: 13773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages.
    Peiris JS; Gordon S; Unkeless JC; Porterfield JS
    Nature; 1981 Jan; 289(5794):189-91. PubMed ID: 7453820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fc gamma R-mediated killing by eosinophils.
    Graziano RF; Looney RJ; Shen L; Fanger MW
    J Immunol; 1989 Jan; 142(1):230-5. PubMed ID: 2521234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T- and B-cell epitopes.
    Mathews JH; Roehrig JT; Brubaker JR; Hunt AR; Allan JE
    J Virol; 1992 Nov; 66(11):6555-62. PubMed ID: 1383567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes.
    Kurlander RJ; Ellison DM; Hall J
    J Immunol; 1984 Aug; 133(2):855-62. PubMed ID: 6736648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological evidence of inter-epidemic infection of feral pigs in New South Wales with Murray Valley encephalitis virus.
    Gard GP; Giles JR; Dwyer-Grey RJ; Woodroofe GM
    Aust J Exp Biol Med Sci; 1976 Jun; 54(3):297-302. PubMed ID: 1016127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-dependent enhancement of Murray Valley encephalitis virus virulence in mice.
    Wallace MJ; Smith DW; Broom AK; Mackenzie JS; Hall RA; Shellam GR; McMinn PC
    J Gen Virol; 2003 Jul; 84(Pt 7):1723-1728. PubMed ID: 12810865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An attenuated variant of Eastern encephalitis virus: biological properties and protection induced in mice.
    Brown A; Officer JE
    Arch Virol; 1975; 47(2):123-38. PubMed ID: 1119939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of infectious Murray Valley encephalitis virus derived from a stably cloned genome-length cDNA.
    Hurrelbrink RJ; Nestorowicz A; McMinn PC
    J Gen Virol; 1999 Dec; 80 ( Pt 12)():3115-3125. PubMed ID: 10567642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells.
    Dingwell KS; Brunetti CR; Hendricks RL; Tang Q; Tang M; Rainbow AJ; Johnson DC
    J Virol; 1994 Feb; 68(2):834-45. PubMed ID: 8289387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the southern limits of Murray Valley encephalitis activity in Western Australia during the 2000 wet season.
    Broom AK; Lindsay MD; Harrington SA; Smith DW
    Vector Borne Zoonotic Dis; 2002; 2(2):87-95. PubMed ID: 12653302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnosis of Murray Valley encephalitis by reverse transcriptase-polymerase chain reaction.
    McMinn PC; Carman PG; Smith DW
    Pathology; 2000 Feb; 32(1):49-51. PubMed ID: 10740807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus.
    Mathews JH; Allan JE; Roehrig JT; Brubaker JR; Uren MF; Hunt AR
    J Virol; 1991 Oct; 65(10):5141-8. PubMed ID: 1832722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.